Projects per year
Personal profile
Research Interests
Immunology, Health Disparities, Immunotherapy, Aging
URL
Area of Expertise
Dr. Jones conducts biomedical and health disparity research to identify mechanisms of disease pathogenesis involved in cancer, infectious, and inflammatory diseases that disproportionately affect underrepresented minority populations. His research program has identified novel mechanisms through which neuroendocrine factors mediate host cellular immune and respiratory inflammatory responses against pneumococcal disease, asthma, and lung cancer, elucidated potential roles through which microbial species directly respond to corticotropin releasing hormone and other hormones to escape host defenses. His most recent research, defining use of “bacterio-mimetic” components for immune-based targeted nanoparticle cancer therapeutics forms the basis of this application.
Dr. Jones is a recipient of the UNTHSC Outstanding Graduate Faculty Award and National Role Model Award. He also serves as Director of the Center for Diversity and International Programs at UNTHSC. Dr. Jones believes strongly in promoting continuing education and professional development for postdoctoral fellows and early-stage faculty. As such, he has taken a keen interest in developing mentoring and professional development skills through active training within the National Research Mentoring Network (NRMN). As a certified master facilitator, Dr. Jones provides training in best mentoring and professional development practices across the country. Dr. Jones directs the NRMN Professional Development Program, NRMN STAR at UNTHSC, and is Principle Investigator of two summer undergraduate research training programs funded by the National Institute of Drug Abuse and National Heart, Lung, and Blood Institute.
Techniques
In vitro and In vivo models of disease
Education/Academic qualification
BS in Microbiology and Immunology, Louisiana State University
MS in Biological Science, Southern University Louisiana
PhD in Biomedical Science, UNT Health Science Center
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
-
Summer Undergraduate Research
Jones, H. (PI) & Basha, R. (CoI)
NIDA: National Institute on Drug Abuse
1/12/23 → 30/11/28
Project: Research
-
AIM-AHEAD Coordinating Center
Vishwanatha, J. (PI), Jones, H. (CoI), Basha, R. (CoI), Sambamoorthi, U. (CoI) & Zhou, B. (CoI)
17/09/21 → 16/03/25
Project: Research
-
HSC Scholars in Cancer Researc
Vishwanatha, J. (PI), Yurvati, A. (CoI), Jones, H. (CoI), Smith, M. (CoI), Berg, R. (CoI), Basha, R. (CoI), Bunnell, B. (CoI) & Mathew, S. (CoI)
Cancer Prevention & Res Inst of TX
31/08/21 → 30/08/26
Project: Research
-
-
Erratum: Enhancement of anti-tumor effect of particulate vaccine delivery system by 'Bacteriomimetic' (Nanomedicine (2015) 10:6 (915-929))
Kokate, R. A., Thamake, S. I., Chaudhary, P., Mott, B., Raut, S., Vishwanatha, J. K. & Jones, H. P., 1 May 2015, In: Nanomedicine. 10, 10, p. 1676 1 p.Research output: Contribution to journal › Comment/debate
-
The embers underneath the CoV-2 pandemic: a semblance of the persistent burn of health inequities and disparities in the United States
Jones, H. P. & Phillips, N. R., Oct 2021, In: Nature Immunology. 22, 10, p. 1188-1189 2 p.Research output: Contribution to journal › Article › peer-review
-
Cytokine and chemokine transcription profile during Mycoplasma pulmonis infection in susceptible and resistant strains of mice: Macrophage inflammatory protein 1β (CCL4) and monocyte chemoattractant protein 2 (CCL8) and accumulation of CCR5+ Th cells
Sun, X., Jones, H. P., Hodge, L. M. & Simecka, J. W., Oct 2006, In: Infection and Immunity. 74, 10, p. 5943-5954 12 p.Research output: Contribution to journal › Article › peer-review
-
Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth
Braden, A. R., Kafka, M. T., Cunningham, L., Jones, H. & Vishwanatha, J. K., May 2009, In: Journal of Nanoscience and Nanotechnology. 9, 5, p. 2856-2865 10 p.Research output: Contribution to journal › Article › peer-review
-
Stress-induced differences in primary and secondary resistance against bacterial sepsis corresponds with diverse corticotropin releasing hormone receptor expression by pulmonary CD11c+ MHC II+ and CD11c- MHC II+ APCs
Gonzales, X. F., Deshmukh, A., Pulse, M., Johnson, K. & Jones, H. P., May 2008, In: Brain, Behavior, and Immunity. 22, 4, p. 552-564 13 p.Research output: Contribution to journal › Article › peer-review